CRISPR Therapeutics AG revenue breakdown overview

CRISPR Therapeutics AG revenue for the last year amounted to 37.31 M USD, the most of which — 37.31 M USD — came from its highest performing source at the moment, Gene-based Medicines, the year earlier bringing 371.21 M USD. The greatest contribution to the revenue figure was made by Switzerland and United States — last year it brought CRISPR Therapeutics AG 37.31 M USD, and the year before that — 371.21 M USD.